AXA SA (CS.PA) Stock Fundamental Analysis
EPA:CS - FR0000120628 - Common Stock
39.82 EUR
-0.08 (-0.2%)
We assign a fundamental rating of 5 out of 10 to CS. CS was compared to 39 industry peers in the Insurance industry. CS has only an average score on both its financial health and profitability. CS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year CS was profitable.
In the past year CS had a positive cash flow from operations.
In the past 5 years CS has always been profitable.
In the past 5 years CS always reported a positive cash flow from operatings.
1.2 Ratios
CS has a Return On Assets of 1.18%. This is comparable to the rest of the industry: CS outperforms 51.28% of its industry peers.
CS's Return On Equity of 16.72% is fine compared to the rest of the industry. CS outperforms 69.23% of its industry peers.
CS's Return On Invested Capital of 1.28% is in line compared to the rest of the industry. CS outperforms 51.28% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CS is in line with the industry average of 2.17%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 16.72% | ||
| ROIC | 1.28% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
1.3 Margins
CS has a Profit Margin (8.52%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CS has grown nicely.
CS has a Operating Margin (11.47%) which is in line with its industry peers.
CS's Operating Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.47% | ||
| PM (TTM) | 8.52% | ||
| GM | N/A |
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CS is destroying value.
The number of shares outstanding for CS has been reduced compared to 1 year ago.
Compared to 5 years ago, CS has less shares outstanding
Compared to 1 year ago, CS has a worse debt to assets ratio.
2.2 Solvency
CS has an Altman-Z score of 0.35. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
With an excellent Altman-Z score value of 0.35, CS belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
The Debt to FCF ratio of CS is 1.41, which is an excellent value as it means it would take CS, only 1.41 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CS (1.41) is better than 76.92% of its industry peers.
CS has a Debt/Equity ratio of 0.65. This is a neutral value indicating CS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.65, CS perfoms like the industry average, outperforming 41.03% of the companies in the same industry.
Even though the debt/equity ratio score it not favorable for CS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 1.41 | ||
| Altman-Z | 0.35 |
ROIC/WACC0.12
WACC10.56%
2.3 Liquidity
A Current Ratio of 0.82 indicates that CS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.82, CS belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
CS has a Quick Ratio of 0.82. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
CS's Quick ratio of 0.82 is amongst the best of the industry. CS outperforms 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.70% over the past year.
Measured over the past years, CS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.09% on average per year.
CS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.40%.
Measured over the past years, CS shows a decrease in Revenue. The Revenue has been decreasing by -8.16% on average per year.
EPS 1Y (TTM)8.7%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%8.56%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%3.72%
3.2 Future
The Earnings Per Share is expected to grow by 6.78% on average over the next years.
CS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.25% yearly.
EPS Next Y14.58%
EPS Next 2Y9.06%
EPS Next 3Y8.11%
EPS Next 5Y6.78%
Revenue Next Year8.2%
Revenue Next 2Y6.61%
Revenue Next 3Y6.69%
Revenue Next 5Y8.25%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.62 indicates a reasonable valuation of CS.
Based on the Price/Earnings ratio, CS is valued a bit cheaper than 74.36% of the companies in the same industry.
CS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.17.
The Price/Forward Earnings ratio is 9.33, which indicates a very decent valuation of CS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CS indicates a somewhat cheap valuation: CS is cheaper than 79.49% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CS to the average of the S&P500 Index (22.78), we can say CS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.62 | ||
| Fwd PE | 9.33 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, CS is valued cheaply inside the industry as 84.62% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.13 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.73
PEG (5Y)0.59
EPS Next 2Y9.06%
EPS Next 3Y8.11%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.99%, CS is a good candidate for dividend investing.
CS's Dividend Yield is a higher than the industry average which is at 4.28.
Compared to an average S&P500 Dividend Yield of 2.34, CS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.99% |
5.2 History
The dividend of CS is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
61.79% of the earnings are spent on dividend by CS. This is not a sustainable payout ratio.
The dividend of CS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP61.79%
EPS Next 2Y9.06%
EPS Next 3Y8.11%
EPA:CS (8/29/2025, 5:00:16 PM)
39.82
-0.08 (-0.2%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners33.99%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap86.34B
Analysts81.48
Price Target45.34 (13.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.99% |
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP61.79%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.46%
PT rev (3m)4.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.7%
EPS NY rev (3m)2.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.8%
Revenue NY rev (3m)1.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.62 | ||
| Fwd PE | 9.33 | ||
| P/S | 0.97 | ||
| P/FCF | 4.13 | ||
| P/OCF | 4.03 | ||
| P/B | 1.9 | ||
| P/tB | 3.58 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.75
EY9.42%
EPS(NY)4.27
Fwd EY10.72%
FCF(TTM)9.65
FCFY24.24%
OCF(TTM)9.87
OCFY24.78%
SpS41.17
BVpS20.98
TBVpS11.12
PEG (NY)0.73
PEG (5Y)0.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 16.72% | ||
| ROCE | 1.62% | ||
| ROIC | 1.28% | ||
| ROICexc | 1.33% | ||
| ROICexgc | 1.74% | ||
| OM | 11.47% | ||
| PM (TTM) | 8.52% | ||
| GM | N/A | ||
| FCFM | 23.44% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 1.41 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.53% | ||
| Interest Coverage | 1.98 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 275.1% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 0.35 |
F-Score7
WACC10.56%
ROIC/WACC0.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)8.7%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%8.56%
EPS Next Y14.58%
EPS Next 2Y9.06%
EPS Next 3Y8.11%
EPS Next 5Y6.78%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%3.72%
Revenue Next Year8.2%
Revenue Next 2Y6.61%
Revenue Next 3Y6.69%
Revenue Next 5Y8.25%
EBIT growth 1Y7.05%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y150.74%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y145.39%
OCF growth 3Y7.85%
OCF growth 5Y9.48%